Earnings Feed
Start Free
Home/Insiders/SANDERLING V LTD PARTNERSHIP
SV
SEC Insider//CIK 0001267960

SANDERLING V LTD PARTNERSHIP

CIK 00012679604 companiesSAN MATEO, CA
SEC Profile

Transactions

50

Companies

4

Filings

5

CIK

0001267960

Recent Transactions

50 trades
  • Other
    CHIMERIX INC

    Common Stock

    2013-11-13−7,543→ 4,153,650 total
  • Other
    CHIMERIX INC

    Common Stock

    2013-11-13−94,633→ 4,161,193 total
  • Conversion
    CHIMERIX INC

    Common Stock

    2013-04-16+695,496→ 1,822,402 total
  • Conversion
    CHIMERIX INC

    Common Stock

    2013-04-16+792,037→ 4,255,826 total
  • Conversion
    CHIMERIX INC

    Common Stock

    2013-04-16+619,852→ 3,213,626 total
  • Conversion
    CHIMERIX INC

    Common Stock

    2013-04-16+771,372→ 2,593,774 total
  • Conversion
    CHIMERIX INC

    Common Stock

    2013-04-16+469,480→ 1,126,906 total
  • Conversion
    CHIMERIX INC

    Common Stock

    2013-04-16+474,330→ 657,426 total
  • Conversion
    CHIMERIX INC

    Common Stock

    2013-04-16+792,037→ 4,143,152 total
  • Conversion
    CHIMERIX INC

    Common Stock

    2013-04-16+183,096→ 183,096 total
  • Conversion
    CHIMERIX INC

    Series E Preferred Stock

    2012-04-16−2,200,490→ 0 total
  • Conversion
    CHIMERIX INC

    Series D Preferred Stock

    2012-04-16−2,738,386→ 0 total
  • Conversion
    CHIMERIX INC

    Series B Preferred Stock

    2012-04-16−1,683,879→ 0 total
  • Conversion
    CHIMERIX INC

    Series F Preferred Stock

    2012-04-16−2,811,735→ 0 total
  • Conversion
    CHIMERIX INC

    Series C Preferred Stock

    2012-04-16−2,469,034→ 0 total
  • Conversion
    CHIMERIX INC

    Series A Preferred Stock

    2012-04-16−650,000→ 0 total
  • Conversion
    CHIMERIX INC

    Series B-1 Preferred Stock

    2012-04-16−1,666,667→ 0 total
  • Purchase
    ENDOCYTE INC

    Common Stock

    2011-12-21$3.16/sh+197,800→ 831,461 total
  • Purchase
    ENDOCYTE INC

    Common Stock

    2011-12-21$3.16/sh+217,800→ 871,461 total
  • Purchase
    ENDOCYTE INC

    Common Stock

    2011-12-20$3.20/sh+217,800→ 653,661 total
  • Purchase
    ENDOCYTE INC

    Common Stock

    2011-12-20$3.20/sh+197,800→ 633,661 total
  • Conversion
    ENDOCYTE INC

    Series C-2 Convertible Preferred Stock

    2011-02-09−33,755→ 0 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+880,831→ 1,017,304 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+99,791→ 113,315 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+215,719→ 249,148 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+88,794→ 100,828 total
  • Conversion
    ENDOCYTE INC

    Series C-3 Convertible Preferred Stock

    2011-02-09−15,405→ 0 total
  • Conversion
    ENDOCYTE INC

    Series B Convertible Preferred Stock

    2011-02-09−22,526→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-1 Convertible Preferred Stock

    2011-02-09−22,526→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-2 Convertible Preferred Stock

    2011-02-09−30,035→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-3 Convertible Preferred Stock

    2011-02-09−13,707→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-3 Convertible Preferred Stock

    2011-02-09−10,049→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-3 Convertible Preferred Stock

    2011-02-09−8,434→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-1 Convertible Preferred Stock

    2011-02-09−255,458→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-2 Convertible Preferred Stock

    2011-02-09−340,612→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-3 Convertible Preferred Stock

    2011-02-09−29,303→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-3 Convertible Preferred Stock

    2011-02-09−435,861→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-3 Convertible Preferred Stock

    2011-02-09−267,491→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-1 Convertible Preferred Stock

    2011-02-09−62,573→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-2 Convertible Preferred Stock

    2011-02-09−83,431→ 0 total
  • Conversion
    ENDOCYTE INC

    Series C-3 Convertible Preferred Stock

    2011-02-09−7,141→ 0 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+880,831→ 1,017,304 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+435,861→ 435,861 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+267,491→ 267,491 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+215,719→ 249,148 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+162,170→ 162,170 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+99,791→ 113,315 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+88,794→ 100,828 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+10,049→ 10,049 total
  • Conversion
    ENDOCYTE INC

    Common Stock

    2011-02-09+8,434→ 8,434 total

Companies

4

Recent Filings

5

Address

400 S. EL CAMINO REAL, SUITE 1200

SAN MATEO, CA, 94402

View on SEC.gov